PEMAZYRE

Serial Number 88616570
Registration 6494001
700

Registration Progress

Application Filed
Sep 13, 2019
Under Examination
Aug 11, 2020
Approved for Publication
Jun 16, 2020
Published for Opposition
Jun 16, 2020
Registered
Sep 21, 2021

Trademark Image

PEMAZYRE

Basic Information

Serial Number
88616570
Registration Number
6494001
Filing Date
September 13, 2019
Registration Date
September 21, 2021
Published for Opposition
June 16, 2020
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Sep 21, 2021
Registration
Registered
Classes
005

Rights Holder

INCYTE HOLDINGS CORPORATION

03
Address
1801 Augustine Cut-Off
Wilmington, DE 19803

Ownership History

INCYTE HOLDINGS CORPORATION

Original Applicant
03
Wilmington, DE

INCYTE HOLDINGS CORPORATION

Owner at Publication
03
Wilmington, DE

INCYTE HOLDINGS CORPORATION

Original Registrant
03
Wilmington, DE

Legal Representation

Attorney
Frances M. Jagla

USPTO Deadlines

Next Deadline
684 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-09-21)
Due Date
September 21, 2027
Grace Period Ends
March 21, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

34 events
Date Code Type Description Documents
Sep 21, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 20, 2021 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Aug 19, 2021 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Aug 5, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 20, 2021 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jul 16, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jul 7, 2021 IUAF S USE AMENDMENT FILED Loading...
Jul 7, 2021 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Feb 5, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 3, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 3, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 3, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 11, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 16, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 16, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 27, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 8, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 18, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 17, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 17, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 16, 2020 ALIE A ASSIGNED TO LIE Loading...
Apr 11, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Apr 11, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 11, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Apr 11, 2020 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Apr 11, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Apr 11, 2020 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Dec 16, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Dec 16, 2019 GNRT F NON-FINAL ACTION E-MAILED Loading...
Dec 16, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 13, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 24, 2019 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Sep 23, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 17, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical preparations for the treatment of hematological disorders; pharmaceutical preparations for the treatment of hypophosphatemia disorders; pharmaceutical preparations for the treatment of myeloproliferative disorders; pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders
First Use Anywhere: 20210200
First Use in Commerce: 20210200

Additional Information

Design Mark
The mark consists of the wording "PEMAZYRE" followed by three overlapping triangles with their common point above an elliptical disc.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005